Clinical Trial Update: Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes using Papaverine with stereotactic body radiotherapy for non-small cell lung cancer, currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Papaverine (papaverine)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Lung Non-Small Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING